LY6K and familial pancreatic carcinoma: The mRNA expression data across multiple studies shows that ovarian, colorectal, gastric, breast, lung, brain and CNS, cervical, esophageal, head and neck and pancreatic cancers express significant high levels of Ly6D, Ly6E, Ly6H, Ly6K.